Ffi Fund Ltd - Sep 17, 2021 Form 4 Insider Report for Clarus Therapeutics Holdings, Inc. (CRXT)

Role
10%+ Owner
Signature
/s/ FFI Fund Ltd., By Nancy Zimmerman, Authorized Representative
Stock symbol
CRXT
Transactions as of
Sep 17, 2021
Transactions value $
-$1,171,712
Form type
4
Date filed
9/21/2021, 06:38 PM
Previous filing
Sep 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRXT Common Stock Sale -$1.17M -127K -5.71% $9.20* 2.1M Sep 17, 2021 See footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ffi Fund Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares of common stock, $0.0001 par value per share ("Shares") of Clarus Therapeutics Holdings, Inc. (the "Issuer"), were sold as follows: (i) 92,973 Shares were sold by FFI Fund Ltd. ("FFI"), (ii) 17,830 Shares were sold by FYI Ltd. ("FYI"), and (iii) 16,557 Shares were sold by Olifant Fund, Ltd. (together with FFI and FYI, the "Bracebridge Funds"). Bracebridge Capital, LLC (the "Investment Manager") is the investment manager of each of the Bracebridge Funds and has the authority to vote and dispose of all the Shares reflected herein.
F2 This price is a weighted-average price. These Shares were sold in multiple transactions at prices ranging from $9.05 to $9.34, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this explanatory note.
F3 Each of the Bracebridge Funds and the Investment Manager disclaims beneficial ownership of the Shares except to the extent of any pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the Shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.